Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition.
Eur J Haematol. 2023 Nov;111(5):729-741. doi: 10.1111/ejh.14069. Epub 2023 Jul 27.
Eur J Haematol. 2023.
PMID: 37501402
Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients.
Serio B, Grimaldi F, Ammirati L, Annunziata M, De Santis G, Perrotta A, De Novellis D, Giudice V, Morini D, Storti G, Califano C, Risitano AM, Pane F, Selleri C.
Serio B, et al.
Cancer Rep (Hoboken). 2024 Apr;7(4):e2044. doi: 10.1002/cnr2.2044.
Cancer Rep (Hoboken). 2024.
PMID: 38662362
Free PMC article.
Item in Clipboard
Persistent decreased bone marrow CD3+ CD56+ T lymphocytes are inversely associated with mature granulocytes in myelodysplastic syndromes.
Serio B, Bertolini A, Gorrese M, Ferrara I, Campana A, Morini D, Picone F, Manzo P, Selleri C, Giudice V.
Serio B, et al.
Eur J Haematol. 2023 May;110(5):575-577. doi: 10.1111/ejh.13932. Epub 2023 Feb 5.
Eur J Haematol. 2023.
PMID: 36660773
No abstract available.
Item in Clipboard
Cite
Cite